Aug 7 (Reuters) - AstraZeneca PLC AZN.L:
ALEXION, ASTRAZENECA RARE DISEASE REACHES AN AGREEMENT WITH THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE (PCPA) FOR ULTOMIRIS FOR THE TREATMENT OF ADULTS WITH NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) AND ADULTS WITH GENERALIZED MYASTHENIA GRAVIS (GMG)